Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q 2025Expect to ...
Higher alcohol consumption was linked to greater risk for cirrhosis and liver-related events among patients with metabolic ...
A phase 2 trial found that Mazdutide reduced liver fat and resolved steatosis in over 60% of participants with MASLD and ...
Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal ...
Steatotic liver disease (SLD), mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic dysfunction and ALD (MetALD), ...
Dr Cyriac Abby Philips, aka The Liver Doc, said Indians should be completely avoiding alcohol – but including unsweetened ...